References
- Madsen F, Faurschou P, Banning AM, Engel AM, Sjogren P, Rosetzsky A. The protective effect of inhaled levomepromazine (Nozinan) on histamine-induced bronchial constriction. Pulm Pharmacol 1993;6(2):129–36 [erratum appears in Pulm Pharmacol 1993;(4):287]
- Costantini D, Trifogli R, Fiaschetti T. On the use of Nozinan (levomepromazine) in preanesthetic medication [Italian]. Acta Anaesthesiologica 1968:Suppl 8:277 and Dahl SG, Hall H. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat. Psychopharmacology 1981;74(2):101–4
- McGee JL, Alexander MR. Phenothiazine analgesia – fact or fantasy? [review; 56 refs]. Am J Hosp Pharm 1979;36(5):633–40
- Fazio AN. Control of postoperative pain: a comparison of the efficacy and safety of pentazocine, methotrimeprazine, meperidine, and a placebo. Curr Ther Res Clin Exp 1070;12(2):73–7
- Skinner J, Skinner A. Levomepromazine for nausea and vomiting in advanced cancer [review; 10 refs]. Hosp Med (Lond) 1999;60(8):568–70
- Molnar J, Beladi I, Foldes I. Studies on antituberculotic action of some phenothiazine derivatives in vitro. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene – Erste Abteilung Originale – Reihe A: Medizinische Mikrobiologie und Parasitologie 1977;239(4):521–6
- Avis SP, Holzbecher MD. A fatal case of methotrimeprazine overdose. J Forensic Sci 1996;41(6):1080–1
- Dahl SG. Pharmacokinetics of methotrimeprazine after single and multiple doses. Clin Pharmacol Ther 1976;19(4):435–42
- Dahl SG, Strandjord RE, Sigfusson S. Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup. Eur J Clin Pharmacol 1977;11(4):305–10
- Lal S, Nair NP, Cecyre D, Quirion R. Levomepromazine receptor binding profile in human brain-implications for treatment-resistant schizophrenia. Acta Psychiatr Scand 1993;87(6):380–3
- Antkiewicz-Michaluk L. The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system. Pol J Pharmacol Pharm 1986;38(4):359–70
- Dahl SG, Hall H. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat. Psychopharmacology 1981;74(2):101–4
- Blin O, Azorin JM, Bouhours P. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients. J Clin Psychopharmacol 1996; 16(1):38–44
- Lal S, Nair NP. Is levomepromazine a useful drug in treatment-resistant schizophrenia? Acta Psychiatr Scand 1992;85(3):243–5
- Nygaard HA, Fuglum E, Elgen K. Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway. Curr Med Res Opin 1992;12(10):615–22
- Maryniak O, Manchanda R, Velani A. Methotrimeprazine in the treatment of agitation in acquired brain injury patients. Brain Injury 2001;15(2):167–74
- Garzotto N, Burti L, Tansella M. A fatal case of pancytopenia due to levomepromazine. Br J Psychiatry 1976;129:443–5
- Ananth JV, Lehmann HE, Ban TA. Agranulocytosis associated with methotrimeprazine (Nozinan) administration: a report of three cases. Can Med Assoc J 1970;102(12):1286–7
- Jarventausta K, Leinonen E. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment. Acta Psychiatr Scand 2000;102(3):231–3
- Eberlein-Konig B, Bindl A, Przybilla B. Phototoxic properties of neuroleptic drugs. Dermatology 1997;194(2):131–5
- Schreinzer D, Frey R, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S. Different fatal toxicity of neuroleptics identified by autopsy. Eur Neuropsychopharmacol 2001;11(2):117–24
- Koski, A, Ojanpera I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Experimental Toxicol 2003;22(5):281–7
- Daniel WA, Syrek M, Rylko Z, Kot M. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver. Pol J Pharmacol 2001;53(6):615–21
- Gram LF, Hansen MG, Sindrup SH, et al. Citalopram: interaction studies with levomepromazine, imipramine, and lithium. Ther Drug Monit 1993;15(1):18–24
Further Reading
- St John AB, Born CK. Characterization of analgesic and activity effects of methotrimeprazine and morphine. Res Commun Chem Pathol Pharmacol 1979;26(1):25–34
- Margat P, Broussot T, Pouly JP. Trial of G. 35020 in 52 cases of depression [French, journal article]. Annales Medico-Psychologiques 1968;1(1):126–32
- Anon. Controlled clinical comparison of 6 neuroleptic drugs. Team of Project “Asprum” [clinical trial, journal article]. Activitas Nervosa Superior 1965;7(3):241–2